Kyndryl Holdings

Kyndryl has completed the acquisition of Healthcare IT Leaders for up to $350 million, including a performance-based earn-out component. Healthcare IT Leaders provides consulting and managed services to health systems, focusing on EHR, ERP, WFM, RCM, digital health, cloud and data. Healthcare IT Leaders’ revenue for the twelve months ended March 31, 2026, represented about 1% of Kyndryl’s 2026 revenue, and the transaction does not change guidance for fiscal 2027. Kyndryl is temporarily suspending its share buyback program to preserve financial flexibility. » Więcej na de.investing.com

At the Citi Global TMT Conference Kyndryl reported a 3% revenue decline in the first quarter of fiscal 2027 but reiterated its full-year guidance of flat to -2%, which includes a 3-percentage-point headwind from reduced IBM content. Management expects low-single-digit revenue growth in 2028, supported by backlog, new bookings, US growth and hyperscaler services. Artificial intelligence and roughly 1,600 deployed agents are expected to increase productivity and profitability; Kyndryl also emphasizes capital discipline, an investment-grade rating and share buybacks (about 8% of outstanding shares repurchased). » Więcej na de.investing.com

Kyndryl has granted Ellen Johnson and Andrew Bonzani substantial equity awards as hiring incentives under the Kyndryl 2026 Employment Inducement Equity Incentive Plan. Johnson received 248,514 performance-based PSUs (up to 180% at maximum performance), 121,248 RSUs vesting annually over four years, and 115,474 RSUs as a new-hire bonus vesting over three years. Bonzani received 138,063 performance-based PSUs (also up to 180%), 67,360 RSUs vesting annually over four years, and 96,228 RSUs as a new-hire bonus vesting over three years. The grants are subject to three-year and multi-year performance conditions and were approved by the Compensation and Personnel Committee pursuant to NYSE Rule 303A.08. » Więcej na de.investing.com